378 related articles for article (PubMed ID: 35715640)
1. Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges.
Trujillo B; Wu A; Wetterskog D; Attard G
Br J Cancer; 2022 Nov; 127(8):1394-1402. PubMed ID: 35715640
[TBL] [Abstract][Full Text] [Related]
2. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer.
Casanova-Salas I; Athie A; Boutros PC; Del Re M; Miyamoto DT; Pienta KJ; Posadas EM; Sowalsky AG; Stenzl A; Wyatt AW; Mateo J
Eur Urol; 2021 Jun; 79(6):762-771. PubMed ID: 33422353
[TBL] [Abstract][Full Text] [Related]
3. Development and Application of Liquid Biopsies in Metastatic Prostate Cancer.
Morrison GJ; Goldkorn A
Curr Oncol Rep; 2018 Mar; 20(4):35. PubMed ID: 29572775
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer and liquid biopsies: Clinical applications and challenges.
Urabe F; Sumiyoshi T; Tashiro K; Goto T; Kimura T; Kobayashi T
Int J Urol; 2024 Mar; ():. PubMed ID: 38551314
[TBL] [Abstract][Full Text] [Related]
5. Liquid biopsy: current technology and clinical applications.
Nikanjam M; Kato S; Kurzrock R
J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
[TBL] [Abstract][Full Text] [Related]
6. Non-Invasive Profiling of Advanced Prostate Cancer via Multi-Parametric Liquid Biopsy and Radiomic Analysis.
Morrison G; Buckley J; Ostrow D; Varghese B; Cen SY; Werbin J; Ericson N; Cunha A; Lu YT; George T; Smith J; Quinn D; Duddalwar V; Triche T; Goldkorn A
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269713
[TBL] [Abstract][Full Text] [Related]
7. Liquid biopsy: ready to guide therapy in advanced prostate cancer?
Hegemann M; Stenzl A; Bedke J; Chi KN; Black PC; Todenhöfer T
BJU Int; 2016 Dec; 118(6):855-863. PubMed ID: 27430478
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Preanalytical Conditions and Implementation of Quality Control Steps for Reliable Gene Expression and DNA Methylation Analyses in Liquid Biopsies.
Zavridou M; Mastoraki S; Strati A; Tzanikou E; Chimonidou M; Lianidou E
Clin Chem; 2018 Oct; 64(10):1522-1533. PubMed ID: 30018056
[TBL] [Abstract][Full Text] [Related]
9. Integration of Liquid Biopsies in Clinical Management of Metastatic Prostate Cancer.
Tulpule V; Morrison GJ; Falcone M; Quinn DI; Goldkorn A
Curr Oncol Rep; 2022 Oct; 24(10):1287-1298. PubMed ID: 35575959
[TBL] [Abstract][Full Text] [Related]
10. Fundamentals of liquid biopsies in metastatic prostate cancer: from characterization to stratification.
van Dessel LF; Martens JWM; Lolkema MP
Curr Opin Oncol; 2020 Sep; 32(5):527-534. PubMed ID: 32675591
[TBL] [Abstract][Full Text] [Related]
11. The application of circulating tumor cell and cell-free DNA liquid biopsies in ovarian cancer.
Balla A; Bhak J; Biró O
Mol Cell Probes; 2022 Dec; 66():101871. PubMed ID: 36283501
[TBL] [Abstract][Full Text] [Related]
12. Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes.
Nimir M; Ma Y; Jeffreys SA; Opperman T; Young F; Khan T; Ding P; Chua W; Balakrishnar B; Cooper A; De Souza P; Becker TM
Cells; 2019 Jul; 8(7):. PubMed ID: 31288377
[TBL] [Abstract][Full Text] [Related]
13. Combined Cell-free DNA and RNA Profiling of the Androgen Receptor: Clinical Utility of a Novel Multianalyte Liquid Biopsy Assay for Metastatic Prostate Cancer.
Fettke H; Kwan EM; Docanto MM; Bukczynska P; Ng N; Graham LK; Mahon K; Hauser C; Tan W; Wang XH; Zhao Z; Zheng T; Zhou K; Du P; Yu J; Huang Y; Jia S; Kohli M; Horvath LG; Azad AA
Eur Urol; 2020 Aug; 78(2):173-180. PubMed ID: 32487321
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of emerging biomarkers in prostate cancer liquid biopsies.
Boerrigter E; Groen LN; Van Erp NP; Verhaegh GW; Schalken JA
Expert Rev Mol Diagn; 2020 Feb; 20(2):219-230. PubMed ID: 31577907
[No Abstract] [Full Text] [Related]
15. Liquid biopsies: Potential and challenges.
Heidrich I; Ačkar L; Mossahebi Mohammadi P; Pantel K
Int J Cancer; 2021 Feb; 148(3):528-545. PubMed ID: 32683679
[TBL] [Abstract][Full Text] [Related]
16. Known epigenetic biomarkers for prostate cancer detection and management: exploring the potential of blood-based liquid biopsies.
Constâncio V; Barros-Silva D; Jerónimo C; Henrique R
Expert Rev Mol Diagn; 2019 May; 19(5):367-375. PubMed ID: 30961397
[TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy in prostate cancer: current status and future challenges of clinical application.
Wang Y; Wang Z; Gang X; Wang G
Aging Male; 2021 Dec; 24(1):58-71. PubMed ID: 34850655
[TBL] [Abstract][Full Text] [Related]
18. Cell-Free DNA Variant Sequencing Using Plasma and AR-V7 Testing of Circulating Tumor Cells in Prostate Cancer Patients.
Lieb V; Abdulrahman A; Weigelt K; Hauch S; Gombert M; Guzman J; Bellut L; Goebell PJ; Stöhr R; Hartmann A; Wullich B; Taubert H; Wach S
Cells; 2021 Nov; 10(11):. PubMed ID: 34831445
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer.
Mollica V; Di Nunno V; Santoni M; Cimadamore A; Scarpelli M; Lopez-Beltran A; Cheng L; Mariani C; Battelli N; Montironi R; Massari F
Expert Rev Mol Diagn; 2020 Feb; 20(2):207-217. PubMed ID: 31640441
[No Abstract] [Full Text] [Related]
20. Liquid biopsy in colorectal cancer.
Najafi S; Majidpoor J; Mortezaee K
Clin Chim Acta; 2024 Jan; 553():117674. PubMed ID: 38007059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
